BaroFold, Inc. to Present at C21 BioVentures Conference

Published: May 18, 2007

BOULDER, Colo.--(BUSINESS WIRE)--BaroFold, Inc., a bio-therapeutics company focused on developing and commercializing improved protein therapeutics based on its proprietary PreEMT™ technology, announced today that Lyndal Hesterberg, President and Chief Executive Officer, will present a corporate overview and update at the C21 BioVentures Conference. The 9th Annual C21 BioVentures: The Private Lifescience Company Conference will be held May 22-24, 2007 in Monterey, California. Dr. Hesterberg’s presentation will be May 23, 2007 at 12:00 p.m. Pacific.

Back to news